Control Subjects
Ten normal subjects, five SLE cases with normal platelet counts (SLE group A), and five SLE cases with thrombocytopenia (less than 50 x 10'/L) and increased megakaryocytes (SLE group B) were used as a control. All SLE cases were studied before treatment. a-Medium was substituted when the T cell suspension was added to the culture system. To study humoral inhibitors, 0. 1 mL of serum from the patient, normal donors, and ten SLE patients, and 0. 1 mL of complement were added to the culture system. After the recovery of megakaryopoiesis, 2 x iO of the patient's T cells (frozen on admission)
were cocultured with 2 x 10 autobogous bone marrow cells. For the coculture studies of CFU-C and CFU-E, 2 x i05 T cells obtained from the patient before treatment and from ten normal subjects were cocultured with 2 x i05 normal albogenic or autologous bone marrow cells to assay CFU-C and CFU-E. For personal use only. on October 3, 2017. by guest www.bloodjournal.org From
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